Read More
Cancer risk lower in people with MS
Beta Interferon not associated with reducing Long-Term disease progression in patients with relapsing remitting MS
Multiple sclerosis patients appear to have a lower cancer risk.
[youtube]http://www.youtube.com/watch?v=qYdN0zkCCvQ[/youtube]
Elaine Kingwell recently had her study published in the Journal of Neurology, Neurosurgery & Psychiatry.
Afsaneh Shirani’s Paper was recently published in the Multiple Sclerosis Journal.
UBC PhD Candidate, Ellen Lu, published her findings in the Multiple Sclerosis Journal (2012).
Mia van der Kop’s recent study was featured on mssociety.ca.